LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/19/2020ACC: 0001209191-20-055250
Officer· Chief Financial Officer
Since Jun 2018
+176.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
176.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+88.00
Price / share
$13.35
Trade value
$1.17K
% of position
2.8%
10/15/2020
3.17K→3.25K
Total
Net shares
+88.00
Net value
$1.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/15/2020 | A · Award | +88.00 | $13.35 | $1.17K | 2.8% | 3.17K | 3.25K |
| Total | +88.00 | $1.17K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
88.00 shares
Shares
+88.00
Strike price
15.70
Held after
88.00
Exercisable
—
10/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock88.00 shares | 10/15/2020 | A · Award | +88.00 | 15.70 | — | 88.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.24M
Total
15.24M indirect15.24M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.24M | Indirect |
| Total | 15.24M | 15.24M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported